on behalf of the International Registry of Acute Aortic Dissection (IRAD) Investigators Background-In patients with acute type B aortic dissection, presence of recurrent or refractory pain and/or refractory hypertension on medical therapy is sometimes used as an indication for invasive treatment. The International Registry of Acute Aortic Dissection (IRAD) was used to investigate the impact of refractory pain and/or refractory hypertension on the outcomes of acute type B aortic dissection. Methods and Results-Three hundred sixty-five patients affected by uncomplicated acute type B aortic dissection, enrolled in IRAD from 1996 to 2004, were categorized according to risk profile into 2 groups. Patients with recurrent and/or refractory pain or refractory hypertension (group I; nϭ69) and patients without clinical complications at presentation (group II; nϭ296) were compared. "High-risk" patients with classic complications were excluded from this analysis. The overall in-hospital mortality was 6.5% and was increased in group I compared with group II (17.4% versus 4.0%; Pϭ0.0003). The in-hospital mortality after medical management was significantly increased in group I compared with group II (35.6% versus 1.5%; Pϭ0.0003). Mortality rates after surgical (20% versus 28%; Pϭ0.74) or endovascular management (3.7% versus 9.1%; Pϭ0.50) did not differ significantly between group I and group II, respectively. A multivariable logistic regression model confirmed that recurrent and/or refractory pain or refractory hypertension was a predictor of in-hospital mortality (odds ratio, 3.31; 95% confidence interval, 1.04 to 10.45; Pϭ0.041).
hypertension, may be signs of extending dissection or impending rupture but have not resulted in any hemodynamic alteration or organ ischemia. The optimal approach for these patients, either medical, endovascular stenting, or surgery, is still debated. 19 Thoracic endovascular aortic repair is frequently adopted, but actual evidence to support this practice for ABAD patients with recurrent pain and/or hypertension is limited.
Clinical Perspective on p 1289
To better define the importance of refractory pain and/or refractory hypertension in ABAD and the optimal approach for these patients, we performed a comprehensive analysis of patients presenting with ABAD with only pain or refractory hypertension but no other complications, enrolled in the International Registry of Acute Aortic Dissection (IRAD). In-hospital outcomes of medical, endovascular, or surgical management were compared between ABAD patients presenting with and without pain and/or refractory hypertension.
Methods

Patient Selection
Patients presenting with ABAD enrolled in IRAD between January 1996 and December 2004 were investigated. IRAD is an ongoing multinational, multicenter registry that includes enrolled patients with acute aortic dissection at 24 large referral centers (for a list of IRAD centers, see the online-only Data Supplement). The rationale and methods used in IRAD have been described previously. 20 ABAD was defined as any acute aortic dissection involving the descending aorta without any entry tear in the ascending aorta and/or in the aortic arch, presenting within 14 days of symptom onset. Intramural hematoma was defined as presence of a regionally thickened aortic wall in the absence of evidence of a double lumen and/or intimal flap regardless of imaging modality. 11 For this analysis, both classic dissection and acute intramural hematoma were included in the study cohort.
Patients were categorized according to risk profile into 2 groups. Patients with recurrent/refractory pain or refractory hypertension but no other clinical complications were defined as intermediate-risk patients (group I). Patients without any clinical complications at presentation were categorized as low-risk or uncomplicated patients (group II). "High-risk" patients with 1 or more of the following complications were excluded from this analysis (nϭ191): shock, periaortic hematoma, spinal cord ischemia, preoperative mesenteric ischemia/infarction, acute renal failure, and limb ischemia. In-hospital outcomes according to presence and type of complication (low risk versus intermediate risk) and method of treatment were analyzed. The study was approved by the institutional review committee at all participating IRAD institutions.
Data Collection
Data were collected with the use of a standardized data form of 290 clinical variables including patient demographics, patient history, clinical presentation, physical findings, imaging studies, management, in-hospital mortality, and adverse events. Completed data forms were forwarded to the coordinating center at the University of Michigan. Data forms were reviewed for internal validity and completeness of data and were then entered into an Access database. For this analysis, 365 ABAD patients were analyzed, of which 69 met our criteria as intermediate risk.
Statistical Analysis
Data are shown as frequencies, percentages, meanϮSD, or median, as appropriate. Categorical variables were compared between ABAD patients presenting with and without refractory pain and/or refractory hypertension with the use of the 2 test and Fisher exact test when appropriate. Continuous variables with an approximately normal distribution were compared between both groups with the Student t test; other continuous variables were investigated with the Mann-Whitney U test. A multiple logistic regression model was fitted with adjustment for the known predictors of in-hospital mortality for ABAD. 8 A value of PϽ0.05 was considered significant. SAS 8.1 software (Cary, NC) was used for all analyses.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Patient Population
Between 1996 and 2004, 69 patients (18.9%) with ABAD presenting with refractory pain and/or hypertension but no other significant clinical complication were identified (group I). During the same period, 296 patients (81.1%) with uncomplicated ABAD were observed (group II). The mean age was 63.5Ϯ14 years, and 32.6% (nϭ119) were female. There were no significant differences between groups in demographics or patient history (Table 1) , except for preexisting hypertension (89.7% versus 72.7%; Pϭ0.003) and Marfan syndrome (7.3% versus 2.1%; Pϭ0.03), which were more frequently present in group I.
In group I (intermediate group), patients presented more frequently with an abrupt onset of pain, migrating pain, and radiating pain ( Table 1 ). Patients in group I underwent a higher number of diagnostic imaging tests (2.34 versus 1.99; Pϭ0.02), including aortography and magnetic resonance imaging. Complete thrombosis of the false lumen was more frequently detected in group II (group I, 1.8% versus group II, 15.9%; Pϭ0.005), whereas patients in group I tended to have partial false lumen thrombosis more frequently. A trend for involvement of arch vessels and abdominal vessels was observed in patients with pain and/or hypertension (Table 1 ). In addition, in group I, a larger mean aortic diameter (4.75 versus 4.32 cm; Pϭ0.08) and a higher incidence of descending thoracic aorta Ͼ6 cm (16.4% versus 6.7%; Pϭ0.02) were detected ( Table 2 ). Patients in group II were more likely to have a normal chest x-ray, whereas widened mediastinum was seen more often in group I.
In-Hospital Management and Outcomes
In total, 75.9% of patients were managed medically, 13.7% of patients underwent surgery, and 6.5% of patients were treated with endovascular methods. Patients in group I were more frequently managed with surgery (36.2% versus 8.4%; PϽ0.001) or endovascular methods (39.1% versus 3.7%; PϽ0.001) than patients in group II (Table 3) . Medical management was more often offered to patients in group II compared with group I (87.8% versus 24.6%; PϽ0.001). In group I, the median time interval between onset of symptoms and any invasive treatment was longer compared with the low-risk group (240 versus 100 hours; Pϭ0.005), as well as for the interval between diagnosis and any invasive treatment (236 versus 72 hours; Pϭ0.004; Table 3 ).
The overall in-hospital mortality was 6.5% but was significantly increased in group I compared with group II (17.4% versus 4.0%; Pϭ0.0003; Table 3 and Figure 1 ). Among group I, the in-hospital mortality rate was 35.6% after medical management, 20% after surgical management, and 3.7% after endovascular management (Pϭ0.019). The in-hospital mortality after medical management was significantly higher in group I compared with group II (35.6% versus 1.5%; Pϭ0.0003; Figure 2 ). Among the 6 patients who expired after medical management in group I, aortic rupture was the cause of death in 4 cases. Mortality rates after surgical (20% versus 28%; Pϭ0.74) or endovascular management (3.7% versus 9.1%; Pϭ0.50) did not differ significantly between the 2 groups (Table 3) .
We used the multiple logistic regression model to examine the relationship of refractory pain and/or refractory hypertension and mortality after adjusting for the effects of known predictors of in-hospital mortality in the overall cohort of 365 ABAD patients. The model suggested that recurrent and/or refractory pain or refractory hypertension (intermediate-risk group) was an independent predictor of in-hospital mortality (odds ratio, 3.31; 95% confidence interval, 1.04 to 10.45; Pϭ0.041). In this cohort, age Ն70 years (odds ratio, 5.11; 95% confidence interval, 1.70 to 15.39; Pϭ0.004) and absence of chest pain at admission (odds ratio, 3.49; 95% confidence interval, 1.01 to 12.09; Pϭ0.048) were predictors of death as well (Table 4 ). A plot of the observed versus the predicted mortality confirmed that these 3 factors discrimi-nate well in death prediction and that there was little departure from a good fit with the data (Hosmer-Lemeshow test: 2 (5 df)ϭ5.05; Pϭ0.655; Figure 3 ).
Discussion
Patients presenting with ABAD have traditionally been categorized as either uncomplicated, for which medical treatment has been accepted as an adequate mode of therapy with mortality rates between 1% and 6%, or complicated, with features such as rupture, spinal cord ischemia, acute renal failure, and mesenteric or limb ischemia, all of which typically require surgical or endovascular intervention and which, even with optimal treatment, are associated with mortality rates of 20% to 30% after surgery 1,7,9 -11 and 10% to 20% after endovascular management. 7, [12] [13] [14] [15] [16] [17] [18] For those patients in the low-risk group, we observed that medical management is associated with excellent in-hospital results (mortality rate, 1.5%) and appears to be the safest in-hospital therapy in the absence of classic complications, refractory hypertension, and/or pain. The significance of ABAD with refractory hypertension and/or refractory or recurrent pain, in the absence of other complications, is currently less well defined. Although some authors have suggested that these signs/symptoms may not result in poorer outcomes and may be treated with medical management and careful monitoring alone, 19 others have argued that refractory pain or hypertension foreshadows impending rupture and an adverse outcome and therefore should be considered for more aggressive intervention. 5, 11, 21 The IRAD database offers a unique opportunity to analyze the outcomes in large numbers of this subset of ABAD patients. In the present analysis, we observed an in-hospital mortality of 17% among patients with refractory hypertension and/or pain, which was significantly higher compared with patients without these symptoms (4%; Pϭ0.0003) but consistently lower than the inhospital mortality of "classic" complicated ABAD. 1, [7] [8] [9] [10] [11] After adjustment for known risk factors, 8 refractory pain and/or hypertension was an independent predictor for in-hospital mortality. ABAD patients presenting with refractory hypertension and/or pain symptoms, in the absence of other complications, therefore are at intermediate risk for an adverse in-hospital outcome.
We observed several differences in patient history, presentation, and diagnostic imaging findings that may have contributed to the poor outcomes of the patients with refractory hypertension and/or pain that have also been reported by others. 8, 9, 22 These include a history of Marfan syndrome (Pϭ0.03), a larger descending thoracic aortic diameter (Pϭ0.08), partial thrombosis of the false lumen (Pϭ0.16), abdominal vessel involvement (Pϭ0.18), and a widened mediastinum on chest x-ray (Pϭ0.006). Interestingly, patients in the intermediate group also presented more frequently with an abrupt onset of pain (Pϭ0.03) and with migrating pain (Pϭ0.0008), which on univariate analyses were associated with decreased mortality, 8 perhaps because such clinical signs led to an earlier diagnosis and more prompt therapy.
In the present study, more invasive treatment of ABAD with refractory hypertension and/or pain was associated with improved outcomes, whereas approximately one third of the patients managed medically expired. In these patients, the most common cause of death was aortic rupture. In the intermediate-risk group, the observed differences in mortality between endovascular and medical management could reflect the effectiveness of endovascular methods, although a selection bias may be present, and patients treated with medical management may have had more unfavorable characteristics such as a higher age or no chest pain at admission (Table 4 ). Recent reports have suggested that endovascular management of complicated ABAD provides a better survival than medical treatment or open surgery. 7, [12] [13] [14] [15] [16] [17] [18] Endovascular approaches are increasingly becoming the first-line treatment for complicated ABAD cases and are increasingly used for uncomplicated and chronic dissections as well. 7, 14 This report suggests that this trend may also be beneficial for patients in the intermediate-risk group presenting with refractory hypertension and/or pain.
Limitations
Several considerations are important when the results of the present study are interpreted. IRAD is an observational study in which participating centers have different approaches to diagnosis and management, creating potential biases in patient selection, which may be minimized in a single-center series. Patients were not randomized to a predetermined management strategy, and the results rather reflect a retrospective observation. In the absence of large randomized trials, and given the rapid evolution of endovascular aortic stent graft therapy for acute aortic syndromes, there remains some uncertainty in regard to the optimal strategy to manage this subset of patients. For this evaluation, we included patients who presented with ABAD between 1996 and 2004. Endovascular methods and treatment strategies have advanced in recent years, and current results of endovascular management may be improved compared with our results. Values are n (%) unless otherewise indicated. The time interval until invasive treatment describes the median time interval between onset of symptoms or diagnosis until invasive treatment. This may further support an endovascular approach for ABAD patients with recurrent pain and/or hypertension.
Furthermore, use of in-hospital mortality as an end point is necessary and important to patients; however, it is not sufficient for a full evaluation of outcomes of patients with ABAD. In particular, long-term survival and quality of life are critical to deciding the "best" strategy for various cohorts. Further studies are needed to address the best therapeutic approaches for patients presenting with refractory hypertension and/or pain. However, the realistic option to randomize these patients for medical versus invasive management appears to be very difficult, given the rarity of the condition, the tendency for each patient to present a truly unique clinical and pathophysiological state, and the fact that interventional and/or surgical approaches represent a rescue strategy for failed response to medical treatment alone.
Conclusion
In completely uncomplicated ABAD patients, medical therapy was associated with excellent in-hospital outcomes. In contrast, the presence of recurrent pain and/or refractory hypertension was associated with increased in-hospital mortality, particularly when managed medically. These observations suggest that aortic intervention, such as via an endovascular approach, may be indicated in this intermediate-risk group. 
